
UNH
- Market cap
- $472B
- Sector
- Health care

In FY2025, revenue rose 7.0% to $428.5B, the operating margin moved from 6.2% to 6.1%, diluted earnings per share rose 6.3% to $20.57 and free cash flow rose 6.5% to $19.9B.
on FY2024
on FY2024
on FY2024
on FY2024
| Check | Figure | Threshold | Result |
|---|---|---|---|
| Five-year revenue growth | 10.8% a year | 5% a year or more | Strength |
| Latest-year revenue growth | 7.0% in FY2025 | below 0%, or below half the five-year rate | Neutral |
| Cash conversion | 105% of net income | 90% or more; below 60% a concern | Strength |
| Operating margin trend | 6.1% against 6.6% | 1 point or more from the five-year average | Neutral |
| Leverage | 1.6x operating income | net cash or 1x or less; above 3x a concern | Neutral |
| Interest cover | Interest expense is not reported for FY2025 | operating income at 8x interest or more | Not applicable |
| Share count | −3.0% since FY2020 | down 5% or more; up 5% or more a concern | Neutral |
| Profit in each year | five of five | net income positive in each of five years | Strength |
Fixed checks on the reported figures. They describe the record and are not a recommendation.
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend |
|---|---|---|---|---|---|---|
| Revenue | $287.6B | $324.2B | $371.6B | $400.3B | $428.5B | |
| Operating margin | 7.5% | 6.8% | 6.4% | 6.2% | 6.1% | |
| Diluted earnings per share | $16.97 | $17.49 | $18.67 | $19.36 | $20.57 | |
| Free cash flow | $16.0B | $16.2B | $16.9B | $18.7B | $19.9B | |
| Cash and short-term investments | $27.3B | $28.7B | $30.0B | $31.3B | $32.7B | |
| Total debt | $49.5B | $56.0B | $62.5B | $69.0B | $75.5B | |
| Net debt (total debt less cash) | $22.2B | $27.3B | $32.5B | $37.7B | $42.8B | |
| Diluted shares, billions | 0.95 | 0.94 | 0.94 | 0.93 | 0.93 |
Latest 10-K, filed 1 Feb 2026: a material change against the previous one. 3 other filings in the last 90 days, each read on the filings page.
3 statements in this 10-K carry no figure and could not be checked.
on FY2025 · 34 analysts
on FY2025 · 34 analysts
vs price · $420.00 to $718.00 · 26 analysts
Revenue by fiscal year
Billions of dollars: reported, then the analysts' mean with their lowest and highest estimate dashed, and Oryn's base case in the accent.
Oryn's line is the base case its DCF run of 8 Sep 2026 stored
| Consensus | Revenue | Growth | EPS | Growth | Analysts | Revision, 90 days |
|---|---|---|---|---|---|---|
| FY2026 | $454.31B | +6.0% | $22.59 | +9.8% | 34 | +1.5% |
| FY2027 | $477.03B | +5.0% | $24.78 | +9.7% | 28 | −0.8% |